Contract

Maternal and neonatal immunisation service to include Respiratory Syncytial Virus (RSV) vaccinations for pregnant women - "20240901 Dorset Perinatal Imms Team"

  • NHS England

F03: Contract award notice

Notice identifier: 2024/S 000-031050

Procurement identifier (OCID): ocds-h6vhtk-04a3cb

Published 27 September 2024, 4:14pm



Section one: Contracting authority

one.1) Name and addresses

NHS England

Wellington House, 133-135 Waterloo Road

London

SE1 8UG

Email

scwcsu.procurement@nhs.net

Country

United Kingdom

Region code

UKI - London

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://www.england.nhs.uk

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Maternal and neonatal immunisation service to include Respiratory Syncytial Virus (RSV) vaccinations for pregnant women - "20240901 Dorset Perinatal Imms Team"

two.1.2) Main CPV code

  • 85140000 - Miscellaneous health services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS England (South West), have made an urgent award under the Provider Selection Regime, maternal and neonatal immunisation services within Dorset.

An urgent award has been made due to unforeseen circumstance not attributable to the relevant authority. Delaying an award in order to conduct a full application of the Regime would pose a risk to patients.

These services include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 weeks.

Since 2023, the Joint Committee on Vaccination and Immunisation (JCVI) has been actively reviewing the latest evidence on immunisation products which can protect both infants and older adults against RSV infection and disease. In summer 2024, the national RSV vaccination programme was announced.

NHS England were made aware of the specific arrangements for RSV immunisation by the Department of Health in June, with contracts needing to start on 1st September 2024.

The specific arrangements meant in the Dorset system there would need to be an alternative solution to in-house provision by the acute trusts of this level of vaccines for pregnant women at this stage of pregnancy.

The RSV vaccine will be offered throughout the year between 1st September 2024 to 30th August 2025.

The total contract value is £250,000.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £250,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKK25 - Dorset

two.2.4) Description of the procurement

Pertussis, Flu and COVID-19 vaccinations for pregnant women, BCG vaccinations for newborn infants, and the roll out of the RSV programme

two.2.5) Award criteria

Quality criterion - Name: to address immediate risks to safety and quality of care / Weighting: 100

Price - Weighting: 0

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

NHS England were made aware of the specific arrangements for RSV immunisation by the Department of Health in June with contracts needing to start on 1st September. The specific arrangements meant in the Dorset system there would need to be an alternative solution to in-house provision by the acute trusts of this level of vaccines for pregnant women at this stage of pregnancy. This circumstance was unforseen by the Commissioner, a delay would pose a risk to patient safety and provided insufficent time to run a procurement process. The urgent award will allow for a procurement process to be followed under PSR.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

1 September 2024

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Dorset HealthCare

SENTINEL HOUSE 4-6 NUFFIELD ROAD NUFFIELD INDUSTRIAL ESTATE

POOLE

BH17 0RB

Country

United Kingdom

NUTS code
  • UKK2 - Dorset and Somerset
Justification for not providing organisation identifier

Not on any register

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £250,000


Section six. Complementary information

six.3) Additional information

This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

NHS England were made aware of the specific arrangements for RSV immunisation by the Department of Health in June with contracts needing to start on 1st September. The specific arrangements meant in the Dorset system there would need to be an alternative solution to in-house provision by the acute trusts of this level of vaccines for pregnant women at this stage of pregnancy. This circumstance was unforseen by the Commissioner, a delay would pose a risk to patient safety and provided insufficent time to run a procurement process. The urgent award will allow for a procurement process to be followed under PSR.

Dorset Healthcare is the current provider of School Aged Immunisation Services and of the local COVID vaccination response and has recent experience of offering BCG and Monkey Pox vaccinations on a surge basis

Decision makers - Managing Director (system development and commissioning) and South West System Oversight and Co-ordination Leadership Team

Conflicts of Interest - None

six.4) Procedures for review

six.4.1) Review body

NHS England

London

Country

United Kingdom